Characterization of a Ca2+ Release-activated Nonselective Cation Current Regulating Membrane Potential and [Ca2+]i Oscillations in Transgenically Derived beta -Cells*

Michael W. RoeDagger , Jennings F. Worley III§, Feng Qian, Natalia TamarinaDagger , Anshu A. MittalDagger , Flora DralyukDagger , Nathaniel T. BlairDagger , Robert J. Mertz§, Louis H. PhilipsonDagger , and Iain D. Dukes§par

From the Departments of Dagger  Medicine and  Pharmacology and Physiology, University of Chicago, Chicago, Illinois 60637 and the § Department of Cell Physiology, Glaxo Wellcome Research Institute, Research Triangle Park, North Carolina 27709

    ABSTRACT
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References

Although stimulation of insulin secretion by glucose is regulated by coupled oscillations of membrane potential and intracellular Ca2+ ([Ca2+]i), the membrane events regulating these oscillations are incompletely understood. In the presence of glucose and tetraethylammonium, transgenically derived beta -cells (beta TC3-neo) exhibit coupled voltage and [Ca2+]i oscillations strikingly similar to those observed in normal islets in response to glucose. Using these cells as a model system, we investigated the membrane conductance underlying these oscillations. Alterations in delayed rectifier or Ca2+-activated K+ channels were excluded as a source of the conductance oscillations, as they are completely blocked by tetraethylammonium. ATP-sensitive K+ channels were also excluded, since the ATP-sensitive K+ channel blocker tolbutamide substituted for glucose in inducing [Ca2+]i oscillations. Thapsigargin, which depletes intracellular Ca2+ stores, and maitotoxin, an activator of nonselective cation channels, both converted the glucose-dependent [Ca2+]i oscillations into a sustained elevation. On the other hand, both SKF 96365, a blocker of Ca2+ store-operated channels, and external Na+ removal suppressed the glucose-stimulated [Ca2+]i oscillations. Maitotoxin activated a nonselective cation current in beta TC3 cells that was attenuated by removal of extracellular Na+ and by SKF 96365, in the same manner to a current activated in mouse beta -cells following depletion of intracellular Ca2+ stores. Currents similar to these are produced by the mammalian trp-related channels, a gene family that includes Ca2+ store-operated channels and inositol 1,4,5-trisphosphate-activated channels. We found several of the trp family genes were expressed in beta TC3 cells by reverse transcriptase polymerase chain reaction using specific primers, but by Northern blot analysis, mtrp-4 was the predominant message expressed. We conclude that a conductance underlying glucose-stimulated oscillations in beta -cells is provided by a Ca2+ store depletion-activated nonselective cation current, which is plausibly encoded by homologs of trp genes.

    INTRODUCTION
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References

Pancreatic islet beta -cell secretion of insulin stimulated by glucose is dependent upon elevations in intracellular calcium concentration ([Ca2+]i)1 (1). Together, two voltage-dependent processes have been proposed to constitute the glucose-stimulated rise in [Ca2+]i: the influx of extracellular Ca2+ through Ca2+ channels (2-4) and the release of intracellular Ca2+ from the endoplasmic reticulum (ER) (5-7). Glucose initiates changes in membrane potential via an increase in cytosolic ATP, derived from the glycolytic reduction of NAD+, that results in block of ATP-sensitive K+ channels (KATP) (8, 9). Consequently, the membrane potential slowly depolarizes from approximately -65 mV, whereupon trains of action potentials occur (the active phase), interrupted by quiescent periods of hyperpolarization (the silent phase), both forming the so-called electrical bursting behavior characteristic of glucose-stimulated islets (10-12). Closely coupled with this bursting activity are oscillations in [Ca2+]i that ultimately determine the oscillatory nature of insulin secretion (5, 11-14). The mechanism underlying these oscillations in membrane potential, [Ca2+]i, and insulin secretion remains uncertain, but most likely stems from a cyclical activation of an ion conductance governed indirectly by metabolism, changes in [Ca2+]i, or some hitherto uncharacterized intracellular mediator (15, 16).

Confounding an early resolution of this puzzle is the profusion of membrane currents present in beta -cells. Thus, in addition to ATP-sensitive K+ current (IKATP) and voltage-dependent Ca2+ (ICa) and Na+ currents, delayed rectifier K+ (IKDR), Ca2+-activated K+ (IKCa), and G-protein-coupled inward rectifier K+ currents have been described, all of which could contribute to the regulation of the beta -cell membrane potential by glucose (17-20). More recently, a nonselective cation current whose conductance is regulated by the Ca2+ content of the ER (ICRAN; Ca2+ release-activated nonselective cation current) was found in mouse beta -cells (21). This current could be activated indirectly by ER Ca2+ store depletion or directly by maitotoxin (MTX) (12, 21). Carried primarily by Na+, ICRAN produces membrane depolarization and indirectly, an elevation in [Ca2+]i, as a consequence of activation of voltage-dependent ICa (21).

Although membrane potential and [Ca2+]i oscillations have been readily recorded from whole mouse islets and beta -cell clusters (11-14, 20), single mouse beta -cells normally do not respond to glucose stimulation with regular oscillatory activity (16). We have previously reported that a stable transgenically derived murine insulinoma cell line (beta TC3-neo) also responds to glucose with large amplitude oscillations in [Ca2+]i when in the presence of 10-20 mM tetraethylammonium (TEA), a blocker of delayed rectifier K+ channels (Kv) (20). We have thus utilized this cell line to characterize and identify the membrane conductance that underlies glucose-stimulated oscillatory activity.

In this article, we provide evidence that activation of ICRAN in beta TC3-neo cells regulates glucose-stimulated [Ca2+]i oscillations and insulin secretion. Furthermore, to characterize the molecular identity of ICRAN, we detected in insulin-secreting insulinoma cells and mouse islets the expression of multiple trp (transient receptor potential) genes that are known to encode intracellular Ca2+ store release-activated channels in other mammalian and insect tissues (22-28). Our findings suggest that the interaction between intracellular Ca2+ stores and plasma membrane conductances is an important mechanism that controls glucose-dependent stimulus response coupling in beta -cells.

    MATERIALS AND METHODS
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References

beta TC3 cells were cultured as described elsewhere (20, 29). A clonal subline (beta TC3-neo) was isolated after transfection with pSV2-neo by electroporation (20) and maintained in the continued presence of 1 mg/ml G418 (Life Technologies, Inc.). Cells were seeded for 4-6 days in Dulbecco's modified Eagle's medium supplemented with 15% normal horse serum, 2.5% fetal calf serum, 50 units/ml penicillin, 50 µg/ml streptomycin. Eighteen hours prior to experiments, medium was changed to RPMI 1640 medium containing 15% dialyzed horse serum, 2.5% dialyzed fetal calf serum, 1 mM glucose, and antibiotics as above. MIN6 cells were cultured essentially as described (30). Islets of Langerhans were isolated from 8-10-week-old C57BL/KsJ (+/+) mice (Jackson Laboratories) as described (5, 9, 12).

Measurement of [Ca2+]i-- beta TC3-neo cells were loaded with Fura-2 by a 25-min incubation at 37 °C in Krebs-Ringer buffer containing (in mM): 119 NaCl, 4.7 KCl, 1.8 CaCl2, 1.2 MgSO4, 1.2 KH2PO4, 25 NaHCO3, 0 glucose, supplemented with 5 µM acetoxymethyl ester of Fura-2 (Molecular Probes Inc.). In some experiments, external NaCl was replaced with equimolar amounts of N-methyl-D-glucamine-Cl. [Ca2+]i was expressed as the ratio change in fluorescence (340/380) as detailed in full elsewhere (9, 20).

Patch Clamp Current Recordings-- Single beta TC3-neo cells were voltage-clamped using perforated patch clamp techniques. Patch electrodes contained 80 mM potassium aspartate, 50 mM KCl, 5 mM NaCl, 5 mM MgCl2, 10 mM HEPES/KOH (pH 7.2), and 100-120 µg/ml nystatin (9, 20). The perfusion medium was a Krebs-Ringer buffer solution as detailed above.

Insulin Secretion Measurements-- beta TC3-neo cells were plated at a density of 25 × 104/cm2 and cultured overnight in RPMI 1640 medium as described above. Insulin secretion measurements were made in the presence of 0 or 1 mM glucose in the presence or absence of TEA, maitotoxin, or thapsigargin, as described previously (20). The concentration of insulin was determined using an SPA assay kit (Amersham Pharmacia Biotech) and calibrated using rat insulin (Novo) as standard.

Reverse Transcriptase-Polymerase Chain Reaction (RT-PCR) Identification and Amplification of Probes for trp-related Gene Expression-- Mouse brain, beta TC3-neo, and MIN6 poly(A)+ RNA were prepared using an oligo(dT) binding method (Quickprep micro mRNA kit, Amersham Pharmacia Biotech) and first strand cDNA was reverse-transcribed using random primers (Superscript II transcriptase, Life Technologies, Inc.). Transcripts of the six known members of the murine trp (mtrp) family (accession number in parentheses) were amplified by polymerase chain reaction (PCR) using the following oligonucleotide primers: mtrp-1 (GenBank>U40980) 5'-GATTTTGGGAAATTTCTGGGAATG-3' (sense) and 5'-TTTATCCTCATGACTTGCTATCA-3' (antisense); mtrp-2 (U40981) 5'-GACATGATCCGGTTCATGTTC-3' (sense) and 5'-CATCAGCATCATCCTCGATCT-3' (antisense); mtrp-3 (U40982) 5'-GACATATTCAAGTTCATGCGTTCTC-3' (sense) and 5'-ACATCACTGTCATCCTCGATCTC-3' (antisense); mtrp-4 (X90697) 5'-CTGCAGATATCTCTGGGAAGG-3' (sense) and 5'-GCTTTGTTCGAGCAAATTTCC-3' (antisense); mtrp-5 (U40984) 5'-TCTACTGCCTAGTACTACTGGC-3' (sense) and 5'-GTAGGAGTTATTCATCATGGCG-3' (antisense); mtrp-6 (U40969) 5'-GATATCTTCAAATTCATGGTCATA-3' (sense) and 5'-GTCCGCATCATCCTCAATTTC-3' (antisense). The PCR protocol used consisted of an initial denaturation at 94 °C for 3 min; followed by five cycles of 94 °C for 1 min, 64 °C for 30 s; followed directly by 25 cycles of 94 °C for 1 min, 60 °C for 1 min, and 72 °C for 30 s.

Products were run on 1.5% agarose gels, visualized by staining with ethidium bromide, and transferred to Hybond-N+ (Amersham Pharmacia Biotech) for subsequent analysis by Southern blot. Oligonucleotides corresponding to sequences within the amplified mtrp-1-3, -5, and -6 cDNAs were end-labeled with 32P and hybridized overnight at 42 °C in 5× SSC, 5× Denhardt's, 0.5% SDS, 125 µg/ml salmon sperm DNA: trp-1 5'-TGTGTGGGCATCTTCTGCGAACAGC-3'; trp-2 5'-AGGAA-TCCGAGAAGCTAGGCAATT-3'; trp3 5'-GGCCAAAGTAAATCCTGCTTTTA-3'; trp-5 5'-GACCAGAGCTATTGATGAACCTAAC-3'; trp-6 5'-AGTCAGTGGTCATTAA-CTACA-3'. After hybridization, blots were washed in 2× SSC at room temperature for 30 min and at 50 °C in 1× SSC. After washing, blots were exposed to X-Omat film for 5 to 20 min at room temperature. The mtrp-4 fragment was probed with the 400-base pair cDNA itself, after labeling with 32P using a random primer kit (Stratagene, La Jolla, CA). The blot was hybridized overnight at 42 °C in 50% formamide, 5× SSC, 5× Denhardt's solution, 0.5% SDS, 125 µg/ml salmon sperm DNA. After hybridization, the blot was washed in 2× SSC, 0.1% SDS for 30 min at room temperature, and in 0.1× SSC, 0.1% SDS at 60 °C for 30 min. The blot was exposed to X-Omat film for 1 h at -70 °C. Sequenced probes were then subcloned for use in Northern blot analysis.

Northern Blot Analysis-- For RNA isolation, beta TC3 cells were grown to near confluence, washed three times with phosphate-buffered saline, and lysed in solution containing 4 M guanidine thiocyanate, 100 mM Tris-HCl (pH 7.5), 1% beta -mercaptoethanol, and 0.5% lauryl sarcosinate. Total RNA was purified by centrifugation through a 0.9-ml cushion of 5.7 M CsCl in a TLS-55 rotor at 53000 rpm for 4 h in the Optima TL ultracentrifuge (Beckman, Palo Alto, CA). Mouse brain RNA was isolated using TRIzol (Life Technologies, Inc.) according to the manufacturer's protocol and purified by centrifugation through CsCl as described above. RNA was size-fractionated in the presence of ethidium bromide (50 µg/ml) in a 1% agarose-formaldehyde gel at 100 V and transferred to Hybond N nylon membranes (Amersham Pharmacia Biotech). The probes used were the subcloned PCR products described in the previous section, except in the case of mtrp-4, for which a full-length mtrp-4 clone derived from a beta TC3 cDNA library was employed.2 Probes were gel-purified and labeled with [alpha -32P]dCTP using Prime-It random primer labeling kit (Stratagene, La Jolla, CA). After overnight hybridization at 68 °C in ExpressHybe solution (CLONTECH) blots were washed to a final stringency of 0.1× SSC, 0.1% SDS at 60 °C and exposed to BioMax MS-1 film with BioMax intensifying screen (Eastman Kodak Corp.) for 18 h to 1 week at -80 °C.

    RESULTS
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References

In contrast to normal mouse islets, the murine insulinoma cell line, beta TC3-neo, does not usually respond to a step increase in glucose concentration with regular oscillatory increases in [Ca2+]i. Instead, a slow rise in [Ca2+]i occurs with occasional intermittent spikes (Fig. 1A). Exposure of beta TC3-neo cells to 20 mM TEA, a blocker of delayed rectifier K+ channels, however, permitted the generation by glucose of large regular oscillations in [Ca2+]i of a type normally seen in mouse islets exposed to nutrients (5, 13, 20) (Fig. 1A). In the absence of glucose, TEA was without effect (n = 5). This glucose dependence suggests that the governing ionic conductance is carried by IKATP as in the case of primary beta -cells, i.e. IKATP sets the resting membrane potential (17, 18). Indeed, activation of IKATP with 250 µM diazoxide fully suppressed the TEA-activated [Ca2+]i oscillations (Fig. 1B). The [Ca2+]i oscillations were also immediately abolished by exposure to either low Ca2+-containing external solutions (50 µM EGTA, no added Ca2+) or 1 µM nitrendipine, indicating their dependence on depolarization-triggered Ca2+ influx through voltage-dependent Ca2+ channels (VDCC) (Fig. 1C).


View larger version (33K):
[in this window]
[in a new window]
 
Fig. 1.   beta TC3-neo cells display voltage-dependent, TEA-activated [Ca2+]i oscillations. A, changes in [Ca2+]i in a single beta TC3-neo cell, expressed as ratiometric changes in Fura-2 fluorescence (F340/F380), following exposure to a maximally stimulating concentration of glucose (1 mM; GLU, open bar). The subsequent addition of tetraethylammonium (20 mM; TEA, filled bar) activated large amplitude oscillations in [Ca2+]i. B, induction of membrane hyperpolarization with diazoxide (250 µM; DZ, hatched bar), an activator of ATP-sensitive K+ channels abolished the oscillations in [Ca2+]i induced by glucose and TEA. C, the [Ca2+]i oscillations induced by glucose and TEA were abolished by maneuvers designed to suppress Ca2+ influx. Both reduction in the extracellular Ca2+ concentration using solutions containing no added Ca2+ and 50 µM EGTA (EGTA, open bar) and blockade of L-type Ca2+ channels using nitrendipine (1 µM; NIT, open bar) reversibly suppressed oscillatory activity.

It has been previously suggested that glucose-induced electrical and [Ca2+]i oscillations result from oscillations in metabolism (15, 31, 32). However, the experiments shown in Fig. 2 (A and B) would indicate that direct modulation of plasma membrane conductances alone is insufficient to induce Ca2+ oscillations. In the absence of glucose, exposure of beta TC3-neo cells to 100 µM tolbutamide to block IKATP induced [Ca2+]i oscillations only in the presence of TEA that were indistinguishable from those generated by glucose (Fig. 2A). Furthermore, membrane depolarization induced by 20 mM KCl was able to similarly substitute for glucose in permitting TEA to induce [Ca2+]i oscillations (Fig. 2B). Thus, a necessity for the conductance regulating the [Ca2+]i oscillations to be coupled to oscillations in KATP activity or glucose metabolism seems excluded.


View larger version (16K):
[in this window]
[in a new window]
 
Fig. 2.   TEA-induced [Ca2+]i oscillations in beta TC3-neo cells can be supported by depolarizing secretagogues in addition to glucose. Pre-exposure to 100 µM tolbutamide (A) or 20 mM KCl (B) induces monophasic rises in [Ca2+]i similar to those of glucose. Addition of 20 mM TEA in both cases activated large amplitude [Ca2+]i oscillations (compare with Fig. 1, A-C).

We were, however, able to measure marked alterations in the [Ca2+]i oscillations stimulated by glucose following exposure to thapsigargin, a selective inhibitor of the ER Ca2+ ATPases (33, 34). Although thapsigargin caused no detectable alteration in [Ca2+]i in the absence of glucose, addition of thapsigargin following exposure to glucose and TEA converted the resulting [Ca2+]i oscillations into a sustained rise in [Ca2+]i (Fig. 3A). Previous studies in mouse pancreatic islets and beta -cells have indicated that the effect of maneuvers to deplete intracellular Ca2+ stores, as exemplified by the action of thapsigargin, result from the activation of ICRAN (12, 21, 34).


View larger version (22K):
[in this window]
[in a new window]
 
Fig. 3.   Stimulation of [Ca2+]i oscillations in beta TC3-neo cells by ER Ca2+ store depletion-activated nonselective cation channels. A, depletion of intracellular Ca2+ stores by exposure to the ER Ca2+-ATPase inhibitor thapsigargin (500 nM; TG, lower bar) converts [Ca2+]i oscillatory activity induced by glucose (1 mM; GLU, open bar) and TEA (20 mM; middle bar) into a sustained rise. In mouse islets, similar maneuvers cause activation of a depolarizing nonselective cation current carried principally by Na+ (21). B, reduction of extracellular Na+ and its equimolar replacement by 119 mM amount of the non-permeating cation N-methyl-D-glucamine (NMDG, lower bar) reversibly ablated the [Ca2+]i oscillations induced by glucose (1 mM; open bar) and TEA (20 mM; middle bar). C, exposure to the Ca2+ store-activated channel blocker SKF 96365 (60 µM; SKF, hatched bar) also ablated the [Ca2+]i oscillations triggered by glucose (1 mM; open bar) and TEA (20 mM; hatched bar). D, the suppressive effect of SKF 96365 on oscillatory activity is not related to block of classical Ca2+ entry pathways. The rise induced by exposure to KCl (20 mM; KCl, open bar) was unaffected by SKF 96365 (60 µM; SKF, filled bar), but completely suppressed by the L-type Ca2+ channel blocker nitrendipine (1 µM; NIT, hatched bar).

The principal permeating ion carrying the depolarizing current through ICRAN in mouse beta -cells is Na+ (21). To test whether ICRAN was involved in regulating the glucose-dependent oscillations in beta TC3-neo cells, we therefore examined the effects of Na+ substitution. Reduction of external Na+ by substitution with the non-permeant cation N-methyl-D-glucamine largely suppressed the [Ca2+]i oscillations induced in beta TC3-neo cells by glucose and TEA (Fig. 3B). Similarly, application of SKF 96365, a putative blocker of intracellular Ca2+ store release-activated channels (35) reversibly abolished the glucose-stimulated oscillations in [Ca2+]i (Fig. 3C). Nonspecific suppressive effects of SKF 96365 on [Ca2+]i were ruled out by the observation that KCl-induced elevations in [Ca2+]i were unimpaired (Fig. 3D).

Application of 100 pM MTX, an agent that directly activates nonselective cation channels in HL60 cells (36) and ICRAN in mouse beta -cells (21), caused an immediate sustained rise in [Ca2+]i, further indicating the prominent role of this channel in regulating [Ca2+]i in beta TC3 cells (Fig. 4A). Similar to its effect on glucose-stimulated [Ca2+]i oscillations, application of SKF 96365 also suppressed the MTX-dependent elevation in [Ca2+]i in beta TC3-neo cells (Fig. 4B). Finally, diazoxide application was able to completely reverse the MTX-induced [Ca2+]i rise (Fig. 4C), indicating that ICRAN was a relatively small current that could be overridden by concomitant activation of IKATP.


View larger version (11K):
[in this window]
[in a new window]
 
Fig. 4.   Maitotoxin causes a depolarization-dependent increase in [Ca2+]i in beta TC3-neo cells related to opening of ER Ca2+ store depletion-activated nonselective cation channels. A, exposure to 50 pM of the dinoflagellate toxin MTX caused a sustained elevation in [Ca2+]i in beta TC3-neo cells. In mouse pancreatic beta -cells, a similar rise in [Ca2+]i was attributed to activation of nonselective cation channels, leading to a depolarization-driven increase in Ca2+ entry through L-type Ca2+ channels (21). B, the maitotoxin-induced rise in [Ca2+]i (50 pM; MTX, open bar) was reversibly attenuated by the Ca2+ store-operated ion channel blocker SKF 96365 (60 µM; SKF, filled bar). C, the maitotoxin-induced elevation in [Ca2+]i could also be reversibly suppressed by application of the ATP-sensitive K+ channel activator diazoxide (250 µM; DZ, filled bar), indicating that the rise in [Ca2+]i was likely secondary to depolarization-dependent activation of L-type Ca2+ channels.

To confirm the actual presence of a nonselective cation channel in beta TC3-neo cells, we carried out perforated patch recordings. Application of 1-100 pM MTX caused the activation of a non-inactivating current with a reversal potential of -10 mV (Fig. 5A), properties identical to ICRAN observed in mouse beta -cells (21); furthermore, both SKF 96365 and external Na+ removal were able to reversibly attenuate the MTX-activated current (Fig. 5, A and B). These findings suggest that the increase in [Ca2+]i induced by MTX, and the ablation of the glucose-stimulated [Ca2+]i oscillations by SKF 96365 or external Na+ removal, were secondary to activation and block of a Ca2+ store-operated, nonselective cation channel, respectively.


View larger version (11K):
[in this window]
[in a new window]
 
Fig. 5.   beta TC3-neo cells possess maitotoxin-sensitive nonselective cation channels A. Perforated patch recordings of membrane current from a single beta TC3-neo cell. Using a 100-ms ramp protocol (-100 mV to 60 mV, shown in inset below panel), traces shown are control (bullet ), and following exposure to 50 pM MTX (black-square), which caused an increase in membrane current recorded over a range of potentials. The reversal potential for this current was -12 mV, as predicted for a nonselective cation channel and similar to a store operated nonselective cation channel reported in mouse pancreatic beta -cells (21). Application of 40 µM SKF 96365 (open circle ) caused a marked suppression of the MTX-activated current, which was reversed on washout of the store-operated channel blocker (square ). B, in the presence of 50 pM MTX (open circle ), reduction of extracellular Na+ and its equimolar replacement by 119 mM of the non-permeating cation N-methyl-D-glucamine (square ) caused a substantial diminution of the MTX-activated current, which was reversed on re-introduction of normal Na+-containing solutions and MTX (bullet ).

We also measured the effects of modulation of ICRAN on insulin secretion. As we described previously (20), in the presence of 20 mM TEA, 1 mM glucose gave a robust stimulation of insulin secretion (Fig. 6). We investigated the effect on insulin secretion of two mechanisms that would lead to the activation of ICRAN. Activation of the store-operated channel by inhibition of the ER Ca2+ ATPase with thapsigargin greatly potentiated glucose-stimulated insulin secretion in the presence of TEA (Fig. 6). Likewise, direct activation of ICRAN with 50 pM MTX also markedly increased glucose-stimulated insulin secretion (Fig. 6). Thus, indirect or direct activation of ICRAN leads to an amplification of glucose-stimulated insulin secretion, presumably by enhancing depolarization-driven influx of Ca2+ (21).


View larger version (9K):
[in this window]
[in a new window]
 
Fig. 6.   Activation of nonselective cation channels modulates glucose-stimulated insulin secretion. Whereas stimulatory concentrations of glucose caused only a minor stimulation of insulin secretion (1 mM glucose, filled bar) compared with basal insulin secretion output (0 mM glucose, open bar), TEA (20 mM) potentiated glucose-stimulated insulin secretion 10-fold. Addition of thapsigargin (1 µM; TG) further augmented the insulin secretion. Exposure to MTX (50 pM)in the presence of 1 mM glucose induced a similar amount of insulin secretion as that produced by the combined addition of TEA and thapsigargin.

To characterize the molecular identity of ICRAN, we used RT-PCR and Southern blots of beta TC3-neo and MIN6 insulinoma cells and mouse islets to identify transcript expression and prepare probes for Northern blot analysis. Primers (see "Materials and Methods") were designed to amplify the six known mouse trp genes (26, 27). Products from all six trp genes were detected in beta TC3-neo cells and mouse brain. In MIN-6 cells, trp-1, trp-2, trp-4, and trp-6 were expressed, whereas trp-3 and trp-5 were not reproducibly observed. In mouse islets all of the trp gene products were evident except trp-5. RT-PCR experiments with mock cDNA synthesis in the absence of reverse transcriptase were done in parallel, and no bands were observed, excluding amplification of genomic DNA (data not shown). All six trp PCR products from the brain and beta TC3 amplifications were cloned and sequenced, revealing identity to those reported previously (26, 27). We then characterized the expression of trp genes using Northern blots comparing total RNA prepared from mouse brain and beta TC3 cells (Fig. 7). This showed that, despite amplification of most of the trp genes by RT-PCR, only mtrp-4 message was readily detectable in beta TC3 cells, while five of six trp transcripts (the exception being trp-2, a putative pseudogene; Ref. 24) were visualized in brain RNA. Prolonged exposures (>1 week) of several blots revealed very faint bands in beta TC3 RNA corresponding to trp-1 and trp-3 (data not shown).


View larger version (40K):
[in this window]
[in a new window]
 
Fig. 7.   Analysis of mammalian trp expression in insulin-secreting cells. Northern blots comparing trp expression in RNA isolated from mouse brain (lane 1) and beta TC3-neo cells (lane 2). Panels 1-6 indicate the trp gene probe employed (i.e. trp1-6). Note that the trp-2 probe (panel 2, arrowhead) gave a faint band at about 7.5 kilobase pairs in mouse brain. The location of the trp-6 transcript is indicated (panel 6, arrowhead). trp-4 expression was nearly equivalent in the mouse brain and beta TC3-neo RNA (panel 4). Lane 3 in panel 4 contains purified brain ribosomal RNA as a control. Each blot shown is representative of at least four experiments.

    DISCUSSION
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References

We have employed a beta -cell model, the beta TC3-neo cell, to study the underlying mechanisms that regulate glucose-induced oscillations of [Ca2+]i and insulin secretion. Previous studies in insulinoma cells and islets have demonstrated a close coupling between glucose-stimulated oscillations in membrane potential and the consequent oscillations in [Ca2+]i and insulin secretion (14, 15, 20). However, precise identification of the signaling events underlying oscillations has remained elusive. In this study, we have demonstrated the importance of a nonselective cation current activated following depletion of intracellular Ca2+ stores in the regulation of glucose-dependent oscillations of [Ca2+]i and show that activation of ICRAN potentiates insulin secretion. Our findings suggest that this ionic conductance generated by the discharge and refilling of intracellular calcium stores plays a critical role in regulating glucose-induced oscillatory signaling in beta -cells.

Similar to the responses elicited in mouse primary beta -cell clusters and islets, glucose stimulation of insulin-secreting beta TC3-neo cells results in synchronous oscillations in membrane potential and [Ca2+]i (20). However, activation of the oscillations required the additional presence of TEA. In this respect, the beta TC3 cells more closely resemble rat islets, which also do not respond to glucose with large amplitude oscillations in [Ca2+]i, but can be induced to do so by TEA (20). This probably reflects subtle differences between the expression levels of K+ channels between beta -cells of different species. Recently, we determined that the glucose-dependent effects of TEA on beta TC3-neo cells stemmed from inhibition of delayed rectifier K+ channels (KDR) (20). beta TC3-neo cells have a similar complement of KDR subtypes to normal rodent beta -cells, and express Shab (Kv2.1)- and Shaw (Kv3.2)-related transcripts (18, 20). Under conditions where IKDR is blocked, beta TC3-neo cells display glucose-dependent oscillatory responses of the types seen in intact mouse islets or beta -cell clusters. This suggests that the beta TC3-neo cell line will prove useful as a relevant model to examine the ion conductances underlying glucose-stimulated oscillatory behavior in islets.

Several models have been advanced to explain islet bursting activity induced by glucose. One of the earliest proposed that Ca2+ influx during the active phase caused a slow rise in [Ca2+]i, which activated IKCa that in turn repolarized the membrane potential and inactivated ICa (37). Our data are not consistent with this model, since oscillations were observed in the presence of 10-20 mM TEA (20), conditions under which IKCa should be completely suppressed by TEA (Kd, 140 µM) (17). A more recent model suggests that cyclic inhibition of IKATP, or a direct coupling between cellular fuel metabolism and electrical activity in beta -cells acts as the beta -cell membrane potential oscillator (15, 32). Our findings that in the presence of complete block of IKATP with tolbutamide, [Ca2+]i oscillations identical in nature to those induced by glucose are produced would rule out a requirement for oscillations in IKATP, and by inference metabolism, being responsible. Although cyclic variations in KATP activity or glucose metabolism were not a prerequisite for the induction and maintenance of [Ca2+]i oscillations, glucose was nonetheless an important activator of oscillatory behavior. This permissive effect of glucose and tolbutamide is most likely related to blockade of the repolarizing influence of IKATP, the predominant ionic current in pancreatic beta -cells. In support of this contention, direct overriding of IKATP using depolarizing concentrations of KCl was similarly able to substitute for both glucose or tolbutamide in permitting the induction of [Ca2+]i oscillations. As will be discussed further, the inhibition of IKATP allows smaller conductance(s) to exert significant effects on the membrane potential and, indirectly, on [Ca2+]i.

In addition to stimulating the influx of Ca2+ as a result of depolarization-induced opening of VDCCs, it has been recently suggested that glucose mobilizes intracellular Ca2+ from the ER (5-7). As a corollary of this triggered release, glucose has been demonstrated by a number of groups to stimulate the sequestration of Ca2+ in the ER (34, 38, 39). The state of filling of the ER with Ca2+ in turn seems to regulate a plasma membrane nonselective cation channel in pancreatic beta -cells, akin to the "capacitative" Ca2+ entry system described in non-excitable cells (40). This pathway permits the refilling of depleted intracellular Ca2+ stores by activation of a voltage-independent Ca2+ current called ICRAC (Ca2+ release-activated Ca2+ current), that directly supplies Ca2+ to the depleted organelle (41). By contrast, in beta -cells ICRAN enhances the entry of Ca2+ through ICa by causing a sustained membrane depolarization (21). We have confirmed the presence of ICRAN in beta TC3 cells using patch clamp techniques, whose properties are indistinguishable from the current previously described in primary mouse beta -cells (21). Thus, the current is activated by exposure to MTX and the principal permeating ion seems to be Na+; the reversal potential of around -10 mV confirms the nonselective nature of the channel.

Since in other cell systems the mobilization of intracellular Ca2+ stores is often oscillatory in nature (42), this suggests that a conductance activated by the state of filling of intracellular Ca2+ stores (e.g. ICRAN) would similarly oscillate and could therefore underlie the membrane potential oscillations seen in islets and beta -cells exposed to glucose. It was therefore of great interest to observe that pharmacological manipulation of ICRAN resulted in alterations in [Ca2+]i oscillations in beta TC3-neo cells that were consistent with such a role for the channel. Thus, depletion of intracellular Ca2+ stores with thapsigargin to induce activation of ICRAN resulted in a conversion of oscillatory alterations in [Ca2+]i to a sustained rise. That this was due to continuous entry of Ca2+ through ICa, activated as a consequence of ICRAN-dependent membrane depolarization, was demonstrated by the ablative effects of the L-type Ca2+ channel inhibitor nitrendipine.3 Consistent with its effects on glucose-stimulated alterations in [Ca2+]i, thapsigargin potentiated the insulin secretion response of beta TC3-neo cells elicited by glucose and TEA. Direct activation of ICRAN following exposure to MTX induced a similar, nitrendipine-sensitive sustained elevation in [Ca2+]i. MTX also stimulated insulin secretion in the presence of glucose alone, to the same extent as that produced by the combined administration of glucose, TEA and thapsigargin. Interestingly, in the absence of glucose, MTX was without effect on insulin secretion,3 consistent with the proposal that the MTX-activated current is of small magnitude and unable to override IKATP, which would be activated under these conditions. Suppression of current flow through ICRAN had the opposite effect on the glucose-stimulated [Ca2+]i oscillations in beta TC3-neo cells. Thus, SKF 96365, a blocker of intracellular Ca2+ store release-activated channels (35) completely suppressed glucose-induced [Ca2+]i oscillations. Although this compound has also been shown to block L-type calcium channels at high concentrations, the demonstration that KCl-induced depolarization raised [Ca2+]i in the presence of SKF 96365 suggests that voltage-dependent calcium channels were not inhibited. Furthermore, reduction of extracellular Na+, the principal permeating ion through ICRAN, similarly ablated the glucose stimulated oscillations.

We initially characterized the putative molecular identity of ICRAN using RT-PCR with Southern blot analysis, and identified trp genes (trp1-6) expressed differentially in two mouse insulinoma cells and islets of Langerhans. These findings are in partial agreement with recent studies in which the expression of mouse trp-1 was reported in MIN6 cells (43). However, upon Northern blot analysis, trp-4 was the only detectable trp transcript expressed in beta TC3 insulinoma cells, whereas five of the six genes were readily identified in mouse brain (Fig. 7).

Drosophila trp and trp-like (trpl) genes encode Ca2+ store-operated Ca2+ channels and inositol 1,4,5-trisphosphate-activated nonselective cation channels, respectively (22, 23). Recent evidence has suggested that mammalian trp family channels may have several activation mechanisms, with functional channels encoded by multiple subunits (44). Mammalian trp genes are unlikely to direct the expression of ICRAC, as none of the expressed trp genes to date are able to reproduce the Ca2+ selectivity or single channel conductance (0.03 picosiemens) of the native channel (44). For example, htrp-1, also termed hTrpC1, encodes a nonselective channel activated by depletion of Ca2+ stores with a single channel conductance of 16 picosiemens (45). Both TrpC1 and TrpC3 can increase calcium entry following depletion of intracellular stores (27). When transfected into murine L(tk-) cells, a mixture of plasmids containing antisense cDNAs for six mouse trp genes eliminated the thapsigargin-induced increase in [Ca2+]i (27), and a similar transfection with a 1.2-kilobase pair antisense fragment to mtrp4 alone also eliminated receptor-stimulated calcium entry (46). mtrp6 was likewise found to increase Ca2+ entry when stimulated by activation of a cotransfected muscarinic receptor, an effect that was blocked by SKF 96365, an agent we employed here to also block store-operated currents (47). The similarity of ICRAN to trp family channels is further supported by the finding of a single channel conductance of 25 picosiemens for the MTX-sensitive nonselective cation channel activated by ER Ca2+ store depletion in fibroblasts, within the range reported for htrp-1 (48). Our findings thus support the likelihood that trp-related genes encode not only the current we have termed ICRAN, but also the Na+-dependent inward currents that cause rises in [Ca2+]i in beta -cells following Ca2+ store depletion with carbachol, acetylcholine, pituitary adenylate cyclase activating polypeptide, and glucagon-like peptide-1 (49-52).

Fig. 8 depicts a model in which ICRAN regulates glucose-stimulated oscillations of membrane potential and [Ca2+]i. This model provides an explanation for the oscillatory behavior of beta TC3-neo cells in the presence of glucose, and may also be applicable to islet responses following nutrient stimulation. An experimental model centered around ICRAN modulation has also recently been advocated to explain the effects of carbachol on [Ca2+]i and membrane potential (49). In conclusion, our data suggest that ICRAN modulation plays a critical role in controlling nutrient-dependent electrical bursting behavior in islets, and also demonstrates that alterations in ICRAN activity modulate insulin secretion. Since defective ER Ca2+ sequestration has been demonstrated in several animal models of non-insulin-dependent diabetes mellitus (53, 54), it is possible that alterations in ICRAN regulation may play a role in aberrant insulin secretion responses in some forms of non-insulin-dependent diabetes mellitus.


View larger version (24K):
[in this window]
[in a new window]
 
Fig. 8.   Proposed model for the role of an ER Ca2+ store depletion-activated nonselective cation channel in regulating [Ca2+]i oscillations in membrane potential and [Ca2+]i in insulin-secreting cells. In the upper panel is shown experimentally observed alterations in [Ca2+]i in a single beta TC3-neo cell following a step increase in glucose from 0 to 1 mM (filled bar), and the subsequent effect of exposure to 20 mM TEA (open bar). The vertical calibration marks represent the F340/F380 fluorescence ratio for the Fura-2 [Ca2+]i estimations. The lower panels represent a schematic beta -cell, comprising (from left to right) an extracellular space, the plasma membrane, an intracellular space, the endoplasmic reticulum membrane, and an intracellular Ca2+ storage compartment. Shown are the predicted changes in plasma membrane ion channel and ER Ca2+ pump activity occurring during the corresponding segments I-IV. The size of the blue shaded area in the storage compartment represents the content of the store. The solid circles in the plasma membrane and ER represent Ca2+ the glucose transporter (GLUT2) and the thapsigargin-sensitive ER Ca2+ ATPase, respectively. The yellow boxes represent membrane ion channels. Going counterclockwise from GLUT2, they are: the ATP-sensitive K+ channel (KATP), the delayed rectifier K+ channel (Kv), the voltage-dependent Ca2+ channel (VDCC), and the calcium store release-activated nonselective cation channel (CRNSC). Their respective permeating cations, K+, Ca2+, and Na+ are shown in the vicinity of the channel entrance vestibule. The large arrows originating in the intracellular Ca2+ storage compartment represent Ca2+ release and the putative retrograde signal emanating from the ER and regulating CRNSC (solid and unfilled, respectively). The influx of Ca2+ through VDCC is determined by the balance between the magnitude (represented by the size of arrow) of outward repolarizing current through KATP and Kv, versus the inward depolarizing current through CRNSC. Thus, Ca2+ influx occurs only when the current flow through CRNSC exceeds that through KATP and Kv. In the absence of glucose, outward K+ current flow through KATP more than offsets the inward current flowing through CRNSC open as a consequence of the partially depleted intracellular Ca2+ stores (panel I). Following exposure to stimulatory concentrations of glucose, cellular ATP begins to rise. This increase initially provides energy substrate to activate Ca2+ pumps located in the ER, thereby loading intracellular Ca2+ stores. As ATP continues to rise, the current flow through KATP diminishes, allowing some membrane depolarization, driven by Na+ entry through CRNSC (panel II), resulting in a partial activation of VDCC and a modest increase in [Ca2+]i. This depolarization, however, also activates the voltage-dependent Kv channels, and the outward flow of K+ acts to prevent further membrane depolarization. Block of Kv channels (with TEA) (panel III) reduces this repolarizing influence. The resultant unfettered depolarization, either directly or indirectly through inositol 1,4,5-trisphosphate (2), eventually triggers release of intracellular Ca2+ stores. The now empty intracellular Ca2+ store induces full activation of CRNSC the consequence of which is an accelerated rate of depolarization, which recruits more VDCCs leading to an augmented influx of Ca2+. Ca2+ influx continues until the ER Ca2+ stores are filled, at which time the store depletion signal switches off and CRNSCs deactivate. Due to residual outflow of K+ through partially inhibited KATP and the closing of CRNSC the membrane hyperpolarizes, thereby deactivating VDCC (panel IV). The assumption as to the hyperpolarizing action of residual KATP is based on the experimental observation that increasing concentrations of tolbutamide or combination of tolbutamide and glucose cause conversion of [Ca2+]i oscillations into a sustained rise (see Footnote 3). A subsequent release of Ca2+ initiates a cycle of ER Ca2+ store release and refilling, which results in cyclical activation and inactivation of CRNSC and thereby indirectly regulates the degree of calcium influx through VDCC (panels III and IV).

    FOOTNOTES

* The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

par To whom correspondence should be addressed. E-mail: id22327{at}glaxowellcome.com.

1 The abbreviations used are: [Ca2+]i, intracellular free Ca2+ concentration; CRNSC, calcium release-activated nonselective cation channel; ER, endoplasmic reticulum; ICa, calcium current; ICRAC, Ca2+ release-activated Ca2+ current; ICRAN, calcium release-activated nonselective cation current; IKATP, ATP-sensitive K+ current; IKCa, calcium-activated K+ current; IKDR, delayed rectifier K+ current; KATP, ATP-sensitive K+ channel; Kv, delayed rectifier K+ channel; mtrp, murine trp; MTX, maitotoxin; PCR, polymerase chain reaction; RT, reverse transcriptase; TEA, tetraethylammonium; trp; transient receptor potential gene; VDCC, voltage-dependent Ca2+ channel.

2 F. Qian and L. H. Philipson, manuscript in preparation.

3 M. W. Roe, A. A. Mittal, L. H. Philipson, and I. D. Dukes, unpublished observations.

    REFERENCES
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References

  1. Prentki, M., and Matschinsky, F. M. (1987) Physiol. Rev. 67, 1185-1248[Free Full Text]
  2. Keahy, H. H. H., Rajan, A. S., Boyd, A. E., III, and Kunze, D. L. (1989) Diabetes 38, 188-193[Abstract]
  3. Rorsman, P., Ämmälä, P., Berggren, P., Bokvist, K., and Larsson, O. (1992) EMBO J. 11, 2877-2884[Abstract]
  4. Dukes, I. D., and Cleemann, L. (1993) Am. J. Physiol. 264, E348-E353[Abstract/Free Full Text]
  5. Roe, M. W., Lancaster, M. E., Mertz, R. J., Worley, J. F., III, and Dukes, I. D. (1993) J. Biol. Chem. 268, 9953-9956[Abstract/Free Full Text]
  6. Rojas, E., Carroll, P. B., Ricordi, C., Boschero, A. C., Stojilkovic, S. S., and Atwater, I. (1994) Endocrinology 134, 1771-1781[Abstract]
  7. Gromada, J, Frøkjær-Jensen, J, and Dissing, S. (1996) Biochem. J. 314, 339-345[Medline] [Order article via Infotrieve]
  8. Cook, D. L., and Hales, C. N. (1984) Nature 312, 446-448[Medline] [Order article via Infotrieve]
  9. Dukes, I. D., McIntyre, M. S., Mertz, R. J., Philipson, L. H., Roe, M. W., Spencer, B., and Worley, J. F., III (1994) J. Biol. Chem. 269, 10979-10982[Abstract/Free Full Text]
  10. Henquin, J. C., and Meissner, H. P. (1984) Experientia (Basel) 40, 1043-1052
  11. Valdeolmillos, M., Santos, R. M., Contreras, D., Soria, B., and Rosario, L. M. (1989) FEBS Lett. 259, 19-23[CrossRef][Medline] [Order article via Infotrieve]
  12. Worley, J. F., III, McIntyre, M. S., Spencer, B., Mertz, R. J., Roe, M. W., and Dukes, I. D. (1994) J. Biol. Chem. 269, 14359-14362[Abstract/Free Full Text]
  13. Gilon, P., and Henquin, J. C. (1992) J. Biol. Chem. 267, 20713-20720[Abstract/Free Full Text]
  14. Gilon, P., Shepherd, R. M., and Henquin, J. C. (1993) J. Biol. Chem. 268, 22265-22268[Abstract/Free Full Text]
  15. Satin, L. S., and Smolen, P. D. (1994) Endocrine 2, 677-687
  16. Keizer, J. (1995) Biophys. J. 68, 2216-2217[Medline] [Order article via Infotrieve]
  17. Ashcroft, F. M., and Rorsman, P. (1989) Prog. Biophys. Mol. Biol. 54, 87-143[CrossRef][Medline] [Order article via Infotrieve]
  18. Dukes, I. D., and Philipson, L. H. (1996) Diabetes 45, 845-853[Abstract]
  19. Philipson, L. H., Rosenberg, M. P., Kuznetsov, A., Lancaster, M. E., Worley, J. F., III, Roe, M. W., and Dukes, I. D. (1994) J. Biol. Chem. 269, 27787-27790[Abstract/Free Full Text]
  20. Roe, M. W., Worley, J. F., III, Mittal, A. A., Kuznetsov, A., DasGupta, S., Mertz, R. J., Witherspoon, S. M., III, Blair, N., Lancaster, M. E., McIntyre, M. S., Shehee, W. R., Dukes, I. D., and Philipson, L. H. (1996) J. Biol. Chem. 271, 32241-42246[Abstract/Free Full Text]
  21. Worley, J. F., III, McIntyre, M. S., Spencer, B., and Dukes, I. D. (1994) J. Biol. Chem. 269, 32055-32058[Abstract/Free Full Text]
  22. Hardie, R. C., and Minke, B. (1992) Neuron 8, 643-651[Medline] [Order article via Infotrieve]
  23. Phillips, A. M., Bull, A., and Kelly, L. E. (1992) Neuron 8, 631-642[Medline] [Order article via Infotrieve]
  24. Wes, P. D., Chevesich, J., Jeromin, A., Rosenberg, C., Stetten, G., and Montell, C. (1995) Proc. Natl. Acad. Sci. U. S. A. 92, 9652-9656[Abstract]
  25. Bennett, D. L., Petersen, C. C. H., and Cheek, T. R. (1995) Curr. Biol. 5, 1225-1228[Medline] [Order article via Infotrieve]
  26. Petersen, C. C. H., Berridge, M. J., Borgese, F., and Bennett, D. L. (1995) Biochem. J. 311, 41-44[Medline] [Order article via Infotrieve]
  27. Zhu, X., Jiang, M., Peyton, M., Boulay, G., Hurst, R., Stefani, E., and Birnbaumer, L. (1996) Cell 85, 661-671[Medline] [Order article via Infotrieve]
  28. Philipp, S., Cavalie, A., Frichel, M., Wissenbach, U., Zimmer, S., Trust, C., Marquart, A., Murakami, M., and Flockerzi, V. (1996) EMBO J. 18, 6166-6171
  29. Efrat, S., Linde, S., Kofod, H., Spector, D., Delannoy, M., Grant, S., Hanahan, D., and Baekkeskov, S. (1988) Proc. Natl. Acad. Sci. U. S. A. 85, 9037-9041[Abstract]
  30. Hamaguchi, K., Gaskins, H. R., and Leiter, H. E. (1991) Diabetes 40, 842-849[Abstract]
  31. Longo, E. A., Tornheim, K., Deeney, J. T., Varnum, B. A., Tillotson, D., Prentki, M., and Corkey, B. E. (1991) J. Biol. Chem. 266, 9314-9319[Abstract/Free Full Text]
  32. Smolen, P., and Keizer, J. (1992) J. Membr. Biol. 127, 9-19[Medline] [Order article via Infotrieve]
  33. Jackson, T. R., Patterson, S. I., Thastrup, O., and Hanley, M. R. (1988) Biochem. J. 253, 81-86[Medline] [Order article via Infotrieve]
  34. Roe, M. W., Lancaster, M. E., Mertz, R. J., Worley, J. F., III, and Dukes, I. D. (1994) Am. J. Physiol. 266, E852-E862[Abstract/Free Full Text]
  35. Rink, T. J. (1990) FEBS Lett. 268, 381-385[CrossRef][Medline] [Order article via Infotrieve]
  36. Musgrave, I. F., Seifert, R., and Schultz, G. (1994) Biochem. J. 301, 437-441[Medline] [Order article via Infotrieve]
  37. Atwater, I., Ribalet, B., and Rojas, E. (1978) J. Physiol. 278, 117-139[Abstract]
  38. Nadal, A., Valdeolmillos, M., and Soria, B. (1994) Am. J. Physiol. 267, E769-E774[Abstract/Free Full Text]
  39. Chow, R. H., Lund, P. E., Loser, S., Panten, U., and Gylfe, E. (1995) J. Physiol. 485, 607-617[Abstract]
  40. Putney, J. W., Jr. (1986) Cell Calcium 7, 1-12[Medline] [Order article via Infotrieve]
  41. Pozzan, T., Rizzuto, R., Volpe, P., and Meldolesi, J. (1994) Physiol. Rev. 74, 595-636[Free Full Text]
  42. Berridge, M. J. (1995) Ann. N. Y. Acad. Sci. 766, 31-43[Medline] [Order article via Infotrieve]
  43. Sakura, H., and Ashcroft, F. M. (1997) Diabetologia 528, 528-532[CrossRef]
  44. Clapham, D. E. (1996) Neuron 16, 1069-1072[Medline] [Order article via Infotrieve]
  45. Zitt, C., Zobel, A., Obukjov, A. G., Harteneck, C., Kalkbrenner, F., Luckhoff, A., and Schultz, G. (1996) Neuron 16, 1189-1196[Medline] [Order article via Infotrieve]
  46. Birnbaumer, L., Zhu, X., Jiang, M., Boulay, G., Peyton, M., Vannier, B., Brown, D., Platano, D., Sadeghi, H., Stefani, E., and Birnbaumer, M. (1996) Proc. Natl. Acad. Sci. U. S. A. 93, 15195-15202[Abstract/Free Full Text]
  47. Boulay, G., Zhu, X., Peyton, M., Jiang, M., Hurst, R., Stefani, E., and Birnbaumer, L. (1997) J. Biol. Chem. 272, 29672-29680[Abstract/Free Full Text]
  48. Dukes, I. D., McIntyre, M. S., and Worley, J. F., III (1995) Biophys. J. 68, A121 (abstr.)
  49. Silva, A. M., Rosario, L. M., and Santos, R. M. (1994) J. Biol. Chem. 269, 17095-17103[Abstract/Free Full Text]
  50. Bertram, R., Smolen, P., Sherman, A., Mears, D., Atwater, I., Martin, F., and Soria, B. (1995) Biophys. J. 68, 2322-2332
  51. Leech, C. A., Holz, G. G., and Habener, J. F. (1995) Endocrinology 136, 1530-1536[Abstract]
  52. Holz, G. G., IV, Leech, C. A., and Habener, J. F. (1995) J. Biol. Chem. 270, 17749-17757[Abstract/Free Full Text]
  53. Roe, M. W., Philipson, L. H., Frangakis, C. J., Kuznetsov, A., Mertz, R. J., Lancaster, M. E., Spencer, B., Worley, J. F., III, and Dukes, I. D. (1994) J. Biol. Chem. 269, 18279-18282[Abstract/Free Full Text]
  54. Veradi, A., Molnar, E., Ostenson, C. G., and Ashcroft, S. J. (1996) Biochem. J. 319, 521-552[Medline] [Order article via Infotrieve]


Copyright © 1998 by The American Society for Biochemistry and Molecular Biology, Inc.